VANCOUVER, Sept. 12 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that a teleconference call and webcast will be held on Wednesday, September 13, 2006 at 8:00am EST (5:00am PST) to discuss results from the Phase 2a pilot study for RSD1235 (oral). A press release will be issued prior to the call.
